Venkatesha Murthy MD

Venkatesha Murthy MD is a psychiatrist by training. He is currently the VP of global clinical science for psychiatry, Takeda Neuroscience Therapeutic Area Unit with strategic and operational management responsibility of clinical development of the NS psychiatry portfolio to registration. Venkatesha has successfully led the registration of Lurasidone (Latuda® an alliance product) in Europe. Prior to joining Takeda, he held multiple positions of increasing responsibility including the therapeutic area clinical lead at the GSK Neurosciences Centre of Excellence for Drug Discovery (CEDD).

He has led global clinical development programs in mood disorders, schizophrenia and Alzheimer’s disease. Prior to joining industry, he was a clinical academic at the MRC Clinical Sciences Centre, Imperial College London, where his research focused on vulnerability markers of major depressive disorder. Venkatesha completed his initial psychiatry training at the National Institute of Mental Health & Neurosciences, Bangalore, India, where he was involved in the discovery of the antidepressant effect of yoga.